Skip to Main Content

Browse issues

The Journal of Clinical Endocrinology & Metabolism Cover Image for Volume 104, Issue 6
Volume 104, Issue 6
June 2019
ISSN 0021-972X
EISSN 1945-7197

Volume 104, Issue 6, June 2019

Print and Online

Case Reports

Dongyun Zhang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1929–1936, https://doi.org/10.1210/jc.2018-02461

Our findings suggest that everolimus may be a novel therapeutic option for selected patients with aggressive PRL-secreting tumors unresponsive to conventional treatments.

Dongyun Zhang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2395–2402, https://doi.org/10.1210/jc.2018-02419

We have described the use of SRL therapy for NCs. Our findings further support a rationale for the use of cold SRLs and/or SRL-directed peptide receptor radionuclide therapy for these neuroendocrine tumors.

Mini-Reviews

Margareta D Pisarska and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1871–1886, https://doi.org/10.1210/jc.2018-01869

Genetics and epigenetics of infertility etiologies and epigenetics of fertility treatment affect implantation and placentation, which affect short- and long-term maternal and fetal/childhood outcomes.

Eva C Coopmans and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1978–1988, https://doi.org/10.1210/jc.2018-01979

Based on our experiences with the Pasireotide LAR and Pegvisomant Study in Acromegaly and on the currently available literature, we provide recommendations to define the position of pasireotide long-acting release in the treatment of acromegaly.

Anna Shalimova and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2239–2249, https://doi.org/10.1210/jc.2018-01315

The present review has summarized key studies assessing the epidemiology, mechanisms, and consequences of cognitive dysfunction in type 1 diabetes.

Clinical Research Articles

Hainan Lan and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1887–1899, https://doi.org/10.1210/jc.2018-02063

Our study shows that pegvisomant may be a moonlighting antagonist.

Davis Sam and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1900–1906, https://doi.org/10.1210/jc.2018-02089

We investigated rates of discordance between imaging and adrenal vein sampling in the work-up of primary aldosteronism. Discordance was common irrespective of interpretation criteria.

Anna U Kraus and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1907–1916, https://doi.org/10.1210/jc.2018-01621

We define the amino acids of high-risk HLA DQB1 alleles in position 57 in cohorts of isolated and polyglandular autoimmune disorders revealing gender-dependent increased susceptibility.

Sofia Enhörning and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1917–1925, https://doi.org/10.1210/jc.2018-02195

In individuals with high plasma concentration of the vasopressin marker copeptin, increased water intake of 1.5 L daily during 6 weeks significantly reduced copeptin and fasting glucose.

Daan M van Velzen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1937–1947, https://doi.org/10.1210/jc.2018-02138

In this prospective observational study, favorable lipid changes were found in transwomen and unfavorable lipid changes found in transmen after 12 months of gender-affirming hormone therapy.

Aaliyah Riccardi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1948–1952, https://doi.org/10.1210/jc.2018-02517

Activating glial cells missing 2 sequence variants are observed to be low-penetrance susceptibility alleles, conferring an increased but still low overall risk of development of typical sporadic parathyroid adenomas.

Alissa A Newman and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1953–1966, https://doi.org/10.1210/jc.2018-01741

Sodium glucose cotransporter 2 inhibition attenuates some of the favorable physiological adaptations to 12 weeks of endurance exercise training in previously sedentary overweight and obese adults.

Subhankar Chakraborty and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1967–1977, https://doi.org/10.1210/jc.2018-01623

Gastric emptying (GE) and symptoms during a GE study explain daily symptoms in diabetic gastroenteropathy. A glucagon-like peptide 1 antagonist did not reduce symptoms during an intestinal lipid infusion.

Victor W Zhong and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1989–1998, https://doi.org/10.1210/jc.2018-01402

We studied the association of proximal HbA1C level with first hypoglycemia requiring hospitalization in adults with incident type 2 diabetes and found a U-shaped association.

Victoria Nisenblat and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1999–2022, https://doi.org/10.1210/jc.2018-01464

The diagnostic accuracy of endometriosis-associated plasma miRNAs was tested in two large independent cohorts and none showed sufficient sensitivity and specificity for a noninvasive diagnostic.

Bruna L Freire and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2023–2030, https://doi.org/10.1210/jc.2018-01971

In the present study, molecular investigation, using massive parallel sequencing, showed effectiveness in diagnosing one in seven patients with prenatal short stature of unknown etiology.

Jakob Skov and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2031–2040, https://doi.org/10.1210/jc.2018-02298

CVD risk in patients with Addison disease is primarily the result of coronary events in women. The glucocorticoid and mineralocorticoid doses correlated with the risk of CVD.

Stefan Z Lutz and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2041–2053, https://doi.org/10.1210/jc.2018-01573

We assessed the role of the amino acid exchange Gly388(385)Arg in the fibroblast growth factor receptor 4 in hepatic lipid accumulation and its implications for glucose metabolism.

Rachel L Boal and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2057–2066, https://doi.org/10.1210/jc.2018-00957

Patients with mitochondrial disease are shorter than the general population, with adult height related to disease severity and rate of disease progression.

Feitong Wu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2067–2074, https://doi.org/10.1210/jc.2018-02321

Youth or long-term dietary calcium intake is not associated with the risk of developing adult impaired glucose metabolism or T2D.

Akihiro Nishimura and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2075–2082, https://doi.org/10.1210/jc.2018-00946

REM-AHI was independently associated with DR, whereas NREM-AHI was not. SDB, especially during REM sleep, could be the potential risk factor for DR.

Tiina Vesterinen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2083–2093, https://doi.org/10.1210/jc.2018-01931

Pulmonary carcinoid tumors express all five somatostatin receptors (SSTRs). Immunohistochemical expression of SSTR3 or SSTR4 or lack of expression of SSTR1 or SSTR2 are potential prognostic factors.

Husam Ghanim and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2094–2102, https://doi.org/10.1210/jc.2018-01832

Testosterone therapy in men with diabetes increases FGF2 expression in skeletal muscle while suppressing myostatin and Mrf4 expression. This may induce satellite cell activation and muscle growth.

Laura G González Briceño and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2103–2111, https://doi.org/10.1210/jc.2018-02523

General and height-specific QoL are improved in short-stature children treated by GH for 1 year, especially in emotional and social scores, according to children and parent questionnaires.

Larissa G Gomes and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2112–2120, https://doi.org/10.1210/jc.2018-02010

We demonstrated the phenotype and genotype features of women who experienced central precocious puberty or precocious menarche due to rare loss-of-function mutations of the DLK1 gene.

Yu-Ru Ma and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2121–2130, https://doi.org/10.1210/jc.2018-01551

We present the first weighted genetic risk-prediction score for Graves disease using 20 single nucleotide polymorphisms and the largest cohort to date. It was stable and convenient, whereas the prediction performance was still modest.

Domenico Tricò and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2131–2139, https://doi.org/10.1210/jc.2018-02166

The rate of appearance of ingested glucose is a key determinant of 1-hour postload glucose excursions in nondiabetic persons, along with early insulin secretion and peripheral insulin sensitivity.

Francisca Caimari and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2140–2146, https://doi.org/10.1210/jc.2018-01516

This study describesendocrine dysfunction in a cohort with POEMS syndrome evaluated by a multidisciplinary team. All patients had regular screening of diabetes, pituitary, thyroid, and bone metabolism.

Hui Wang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2153–2162, https://doi.org/10.1210/jc.2018-01468

Younger age at diabetes diagnosis, better baseline insulin sensitivity, and improvements of acute insulin secretion and insulin sensitivity after treatment were all predictors of 2-year remission.

Giorgio Bedogni and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2163–2170, https://doi.org/10.1210/jc.2018-01998

Four percent of the 391 1-year-old toddlers of the Feeding Study had BL. PNPLA3 gene CG/GG variants, toddler’s anthropometry, and maternal weight gain were associated with BL.

Daniel A Dumesic and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2171–2183, https://doi.org/10.1210/jc.2018-02086

Normal-weight women with PCOS have increased adipose-IR and altered ASC gene expression associated with hyperandrogenism and IR.

Bob Z Sun and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2184–2194, https://doi.org/10.1210/jc.2018-02400

Recent exposure to progesterone is associated with sleep-specific slowing of LH pulse frequency during the follicular phase in early postmenarchal girls but not with intercycle FSH dynamics.

Murielle Bochud and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2195–2215, https://doi.org/10.1210/jc.2018-01942

The association of different steroid hormones with muscle mass and function was examined in the general population. As one result, cortisol metabolites appear to exert age-specific anabolic effects.

Yevgeniya S Kushchayeva and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2216–2228, https://doi.org/10.1210/jc.2018-02289

We evaluated thyroid abnormalities in extreme insulin resistance due to lipodystrophy or INSR mutation. Children in both groups had high prevalence of nodules. INSR−/− patients had thyromegaly.

Ada S Cheung and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2229–2238, https://doi.org/10.1210/jc.2018-01954

Levator ani, iliopsoas, quadriceps, and gluteus maximus muscles are selectively androgen responsive. Whether losses with androgen deprivation contribute to clinical deficits requires further study.

Jonas Esche and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2250–2256, https://doi.org/10.1210/jc.2018-02108

Peripheral quantitative CT analysis at the forearm of healthy children and adolescents revealed metabolically adverse relationships for a marker of bone marrow adipose tissue with glucocorticoid secretion and body fatness.

Haekyung Lee and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2257–2266, https://doi.org/10.1210/jc.2018-01935

Obese patients have elevated urinary mitochondrial DNA (mtDNA) copy number. Bariatric surgery reduces especially high urinary mtDNA copy number.

Joseph Lunyera and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2267–2276, https://doi.org/10.1210/jc.2018-01747

We elucidate a potential benefit of higher plasma 25-hydroxyvitamin D for CKD in a subset of blacks with diabetes and genetic variants that confer lower levels of the biologically active hormone.

Marjaana Mäkinen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2277–2285, https://doi.org/10.1210/jc.2018-02094

Umbilical cord serum samples were measured for 25[OH]D in 382 case children developing either islet autoimmunity or T1D, and in 382 matched controls. The levels were low and not associated with T1D.

Etty Kruzel-Davila and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2286–2294, https://doi.org/10.1210/jc.2018-02482

Relationships between JC viruria and DKD were assessed. Just as in nondiabetic nephropathy, JC viruria showed a protective association with DKD.

Marie-Christine Simon and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2295–2304, https://doi.org/10.1210/jc.2018-02057

In a direct comparison of carefully matched patients with type 1 and 2 diabetes, we delineated diabetes type-specific correlates of insulin resistance, as measured using the clamp technique.

Joseph S Ross and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2305–2314, https://doi.org/10.1210/jc.2018-02197

Brand-name thyroid hormone product use declined from 2007 to 2016 among three large, national insurer beneficiary populations, with certain patient characteristics being associated with brand-name use.

Alexander Siegfried Busch and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2315–2324, https://doi.org/10.1210/jc.2018-02249

We studied 1075 men with azoospermia who underwent testicular sperm extraction. We observed a significant contribution of a common genetic variant of FSHB on sperm retrieval rate.

Daisuke Sugimoto and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2325–2333, https://doi.org/10.1210/jc.2018-02190

Even in nonobese, apparently healthy, Japanese men, reduced adipose tissue insulin sensitivity was associated with clinical features of metabolic syndrome.

Beom-Jun Kim and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2334–2342, https://doi.org/10.1210/jc.2018-02481

Increased kynurenine levels during aging may contribute to the bone fragility seen in the elderly through the stimulation of bone resorption, with a resultant imbalance in bone remodeling.

Georgiana Sitoris and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2346–2354, https://doi.org/10.1210/jc.2018-02303

The detection rate of subclinical hypothyroidism with targeted high-risk case finding screening can be improved when obesity body mass index 30 to 39.9 kg/m2 and a Caucasian background are added to the American Thyroid Association guidelines defined risk factors.

Nimesh A Jayasuriya and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2355–2366, https://doi.org/10.1210/jc.2018-02312

A lower maternal cortisol-to-cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia.

Segolene Hescot and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2367–2374, https://doi.org/10.1210/jc.2018-01968

Retrospective study that identifies hormonal hypersecretion as an independent significant prognostic factor of worst overall survival, whereas SDHB mutations have no prognostic impact.

Oskar Ragnarsson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2375–2384, https://doi.org/10.1210/jc.2018-02524

Patients with CD in remission have a more than twofold increased mortality, mainly due to cardiovascular diseases, but also due to infections and suicide.

Ferdinand Roelfsema and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2385–2394, https://doi.org/10.1210/jc.2018-02639

Low-range physiological E2 concentrations do not affect spontaneous or ghrelin-stimulated pulsatile GH secretion. P4 inhibits ghrelin-stimulated GH secretion in a concentration-dependent fashion.

Letters to the Editor

Yasuhiro Naiki and Maki Fukami
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 1926–1927, https://doi.org/10.1210/jc.2018-02529
Phyllis W Speiser and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 1928, https://doi.org/10.1210/jc.2018-02629
Paolo Vercellini and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2147–2148, https://doi.org/10.1210/jc.2018-02494
Valerie A Flores and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 2149, https://doi.org/10.1210/jc.2018-02712
Leon Fogelfeld and Michael Morkos
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 2343, https://doi.org/10.1210/jc.2019-00024
Michael Stowasser and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2344–2345, https://doi.org/10.1210/jc.2019-00179

Corrections

The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2054–2056, https://doi.org/10.1210/jc.2019-00527
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 2150, https://doi.org/10.1210/jc.2019-00730
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 2151, https://doi.org/10.1210/jc.2019-00844
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Page 2152, https://doi.org/10.1210/jc.2019-00750

Print Abstracts—Full Content Online Only

Clinical Research Articles

Markus Juonala and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2403–2411, https://doi.org/10.1210/jc.2018-02501

In this longitudinal 28-year follow-up study including 1422 individuals, parental smoking and elevated cotinine levels in childhood were associated with lower bone mineral density in adulthood.

Jane A Cauley and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2412–2418, https://doi.org/10.1210/jc.2018-02047

Serum estradiol measurements over the menopause were predictive of future fractures.

Qiu Du and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2419–2434, https://doi.org/10.1210/jc.2018-01851

circOMA1 could promote NFPA progression by acting as the sponge of tumor suppressor miR-145-5p to regulate the TPT1 signaling pathway, revealing a therapeutic target in the tumorigenesis of NFPAs.

Esben Thyssen Vestergaard and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2435–2442, https://doi.org/10.1210/jc.2018-02601

Intravenous infusion of UAG for 6 hours did not affect plasma glucose, insulin sensitivity, lipolysis, or energy expenditure in men with T2DM.

Nelson B Watts and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2443–2452, https://doi.org/10.1210/jc.2018-01965

Self-reported invasive OPEs were common in women treated with denosumab up to 10 years and were associated with increased ONJ incidence; however, the overall rate of ONJ was low.

Irene T Lee and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 6, June 2019, Pages 2453–2461, https://doi.org/10.1210/jc.2018-02552

Independent of BMI, chronic exposure to glucocorticoids due to Cushing disease increases the presence of adipose tissue macrophages, a hallmark of adipose tissue inflammation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close